Morbidity, mortality and survival rates of non-small cell lung cancer patients who underwent lobectomy with pulmonary artery reconstruction compared to those of the patients who underwent pneumonectomy

Basit Öğe Kaydı
dc.authoridCelalettin Kocatürk / 0000-0003-2583-4880en_US
dc.authorscopusidCelalettin Kocatürk / 8535429200
dc.authorwosidCelalettin Kocatürk / JGU-1463-2023
dc.contributor.authorÇınar, Hüseyin Ulaş
dc.contributor.authorKocatürk, Celalettin
dc.contributor.authorCansever, Levent
dc.contributor.authorCeyhan, Süleyman
dc.contributor.authorBedirhan, Mehmet Ali
dc.date.accessioned2022-03-03T12:48:54Z
dc.date.available2022-03-03T12:48:54Z
dc.date.issued2020en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground: Pulmonary artery reconstruction can be preferred as an alternative to pneumonectomy, to spare the functional lung parenchyma in lung cancer. This study aimed to evaluate the morbidity, mortality and survival rates of the patients who had undergone pulmonary artery reconstruction due to central non-small cell lung cancer (NSCLC) and also to compare their data with those of the patients who had undergone pneumonectomy. Materials and Methods: In this study, 88 patients who underwent pneumonectomy (group PN) and 20 patients who underwent standard or sleeve lobectomy (double sleeve) with pulmonary artery reconstruction (group PAR) for NSCLC with stages I-IIIA between January 2005 and December 2010 were evaluated retrospectively. The morbidity and mortality rates, durations of the hospital and intensive care unit stay, 5-year and mean survival rates of the homogenous patient groups were analyzed comparatively. Results: The postoperative morbidity rate was 30% in the PAR group and 53% in the PN group (p = 0.77). The bronchial complication rate was 0% in the PAR group and 15% in the PN group (p = 0.04). The 30-day mortality rate was 5% in the PAR group and 5.6% in the PN group (p = 1). The median follow-up period for all patients was 31.5 months (range: 0-84 months) and total 5-year survival was 56.2%. In early-stage tumors (stage I + stage II), total 5-year survival rate was 64% in the PAR group and 60% in the PN group (p = 0.7). In late-stage tumors (stage III), total 5-year survival rate was 52% in the PAR group and 30% in the PN group (p = 0.04). No local recurrence was observed in either group during the follow-up period. Conclusions: In central lung tumors, to avoid pneumonectomy, major anatomical lung resection with pulmonary artery reconstructions can safely be performed with acceptable morbidity and mortality rates. Oncological outcomes of pulmonary angioplasty procedures regarding survival and local recurrence are not worse than those of pneumonectomy. Even in advanced stage lung tumors, these procedures can be an alternative to more radical operations such as pneumonectomy.en_US
dc.identifier.citationÇINAR H. U,KOCATÜRK C,CANSEVER L,CEYHAN S,BEDİRHAN M. A (2020). Morbidity, mortality and survival rates of non-small cell lung cancer patients who underwent lobectomy with pulmonary artery reconstruction compared to those of the patients who underwent pneumonectomy. Current Thoracic Surgery, 5(1), 1 - 9.en_US
dc.identifier.doi10.26663/cts.2020.0001en_US
dc.identifier.endpage9en_US
dc.identifier.issn2548-0316en_US
dc.identifier.issn2548-0316en_US
dc.identifier.issue1en_US
dc.identifier.startpage1en_US
dc.identifier.trdizinid492895en_US
dc.identifier.urihttps://doi.org/10.26663/cts.2020.0001
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2521
dc.identifier.volume5en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorKocatürk, Celalettin İbrahim
dc.language.isoenen_US
dc.relation.ispartofCurrent Thoracic Surgeryen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPulmonary Artery Resectionen_US
dc.subjectPulmonary Angioplastyen_US
dc.subjectLung Canceren_US
dc.subjectBronchoplastyen_US
dc.subjectPneumonectomyen_US
dc.titleMorbidity, mortality and survival rates of non-small cell lung cancer patients who underwent lobectomy with pulmonary artery reconstruction compared to those of the patients who underwent pneumonectomyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
pdf_CTS_97.pdf
Boyut:
336.22 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu